A population-based study of cardiovascular disease mortality risk in US cancer patients

European Society of Cardiology: Cardiovascular Disease Statistics 2017

(2017) et al.   EUROPEAN HEART JOURNAL

Risk of cardiac death among cancer survivors in the United States: a SEER database analysis

(2017) Omar Abdel-Rahman   Expert Review of Anticancer Therapy

Anticipating the "Silver Tsunami": Prevalence Trajectories and Comorbidity Burden among Older Cancer Survivors in the United States

(2016) S. M. Bluethmann et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Shared Risk Factors in Cardiovascular Disease and Cancer

(2016) Ryan J. Koene et al.   CIRCULATION

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

(2016) Piotr Ponikowski et al.   EUROPEAN HEART JOURNAL

2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines

(2016) Jose Luis Zamorano et al.   EUROPEAN JOURNAL OF HEART FAILURE

High cardiovascular disease mortality after endometrial cancer diagnosis: Results from the Surveillance, Epidemiology, and End Results (SEER) Database

(2016) Ashley S. Felix et al.   INTERNATIONAL JOURNAL OF CANCER

Cardiac Toxicity After Radiation for Stage III Non-Small Cell Lung Cancer: Pooled Analysis of Several Prospective Dose-Escalation Trials Delivering 70 to 90 Gy

(2016) K. Wang et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Cardiovascular Disease Among Survivors of Adult-Onset Cancer: A Community-Based Retrospective Cohort Study

(2016) Saro H. Armenian et al.   JOURNAL OF CLINICAL ONCOLOGY

Cardiotoxicity associated with CTLA4 and PD1 blocking immunotherapy

(2016) Lucie Heinzerling et al.   Journal for ImmunoTherapy of Cancer

Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013

(2015)   LANCET

Clinical risk factors for the development of hypertension in patients treated with inhibitors of the VEGF signaling pathway

(2014) Ole-Petter R. Hamnvik et al.   CANCER

Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer

(2013) Sarah C. Darby et al.   NEW ENGLAND JOURNAL OF MEDICINE

Late Cardiac Effects of Cancer Treatment

(2012) Daniel J. Lenihan et al.   JOURNAL OF CLINICAL ONCOLOGY

Risk of Heart Failure in Breast Cancer Patients After Anthracycline and Trastuzumab Treatment: A Retrospective Cohort Study

(2012) E. J. A. Bowles et al.   JNCI-Journal of the National Cancer Institute

Trastuzumab-Related Cardiotoxicity Following Anthracycline-Based Adjuvant Chemotherapy: How Worried Should We Be?

(2010) Patrick G. Morris et al.   JOURNAL OF CLINICAL ONCOLOGY

Cardiovascular Risk Factors and Morbidity in Long-Term Survivors of Testicular Cancer: A 20-Year Follow-Up Study

(2010) Hege S. Haugnes et al.   JOURNAL OF CLINICAL ONCOLOGY

Cardiovascular Safety of VEGF-Targeting Therapies: Current Evidence and Handling Strategies

(2010) F. Girardi et al.   ONCOLOGIST

Socioeconomic status and cardiovascular disease: risks and implications for care

(2009) Alexander M. Clark et al.   Nature Reviews Cardiology

Cardiac Toxicity of Sunitinib and Sorafenib in Patients With Metastatic Renal Cell Carcinoma

(2008) Manuela Schmidinger et al.   JOURNAL OF CLINICAL ONCOLOGY